Latest News about Stories That Matter
Recent news which mentions Stories That Matter
From Benzinga
FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months
May 02, 2025
From Benzinga
From Benzinga
From Benzinga
Deal Dispatch: Chef Boyardee, Crumbl Appear Tasty To Buyers While Bankruptcies Tick Upward
May 02, 2025
From Benzinga
'We're Not Guessing The Market, We're Managing It': Inside TSPY's Bold Strategy With CEO Si Katara
May 02, 2025
From Benzinga
From Benzinga
Eli Lilly Stock Offers Buying Opportunity For Goldman Sachs. Concerns Over CVS Setback Are Overblown, Analysts Say
May 02, 2025
From Benzinga
From Benzinga
Apple Stock Faces 'Tariff-Related Headwinds': 4 Analysts Break Down Q2 Results, What's Next
May 02, 2025
From Benzinga
Drug Maker Amneal Highlights Strong Commercial Uptake For Parkinson's Drug But Q1 Earnings Are Mixed
May 02, 2025
From Benzinga
Nasdaq 100 Leads Wall Street Rally As China Signals Openness To Fentanyl Talks, Easing Trade Tensions
May 02, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Wall Street Eyes 9th Straight Day Of Gains, Apple Falls As Chinese Sales Disappoint: What's Driving Markets Friday?
May 02, 2025
From Benzinga
Trump's First 100 Days Fuel Gold, Crush Stocks: BofA Strategist Sees Soft Macro Masked By Hard AI Bets
May 02, 2025
From Benzinga
From Benzinga
Taiwan Semiconductor Gains On Strong Earnings From Meta And Microsoft Boosting AI Demand
May 02, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
AstraZeneca's Triple-Combination Therapy Breztri Hits Primary Goals In Two Pivotal Studies For Asthma
May 02, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
